Chronic autoimmune disease characterised by well-demarcated, erythematous, scaly plaques
Aetiology
Genetic predisposition + environmental triggers
Associated with specific HLA types
Equal sex incidence
Two peaks in incidence - 20s and 50s
Precipitating factors
Stress
Trauma
Alcohol and smoking
Infection - strep throat
Drugs - β-blockers, lithium, anti malarial drugs, swift withdrawal of topical or systemic steroids ('rebound' psoriasis)
Pathophysiology
Triggered by environmental factors in genetically susceptible individuals
Bacterial pharyngitis, Koebner phenomenon (mild trauma to skin), interferon therapy, drugs
Hallmark of skin lesions is inflammation
Plaques are reversible
Keratinocytes under stress (environmental factors) release factors that stimulate plasmacytoid DC to produce IFN⍺, and also release Il-1β/IL-6 and TNF
Chemical signals activate DC, which migrate to skin draining lymph node and present to and activate T cells (TH1 and TH17)
T cells stimulate an inflammatory cascade in the dermis involving anti-microbial peptide release and neutrophil-attracting chemokines
Complement attracts neutrophils to keratin layer → Munro micro abscesses
Results in keratinocyte proliferation